157 related articles for article (PubMed ID: 7372548)
1. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic.
Mine Y; Kamimura T; Nonoyama S; Nishida M; Goto S; Kuwahara S
J Antibiot (Tokyo); 1980 Jan; 33(1):36-43. PubMed ID: 7372548
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
Neu HC; Kamimura T
Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergism of FR-31564, a new phosphonic acid antibiotic.
Yokota Y; Murakawa T; Nishida M
J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590
[TBL] [Abstract][Full Text] [Related]
4. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
Hara T; Araake M; Watabe H
Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
[TBL] [Abstract][Full Text] [Related]
5. [Antibacterial activities of monobactams against fresh clinical isolates].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Kato M; Sato K
Jpn J Antibiot; 1988 Nov; 41(11):1600-22. PubMed ID: 3210297
[TBL] [Abstract][Full Text] [Related]
6. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
Grimm H
Infection; 1979; 7(5):256-9. PubMed ID: 389806
[TBL] [Abstract][Full Text] [Related]
7. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability.
Kojo H; Shigi Y; Nishida M
J Antibiot (Tokyo); 1980 Jan; 33(1):44-8. PubMed ID: 7378171
[TBL] [Abstract][Full Text] [Related]
8. [Bacteriological studies on fosfomycin. Antibacterial activity in vitro and in vivo (author's transl)].
Miyauchi K; Yoshida T; Kasai T; Saito T; Hirano H
Jpn J Antibiot; 1975 Jun; 28(3):320-30. PubMed ID: 807758
[TBL] [Abstract][Full Text] [Related]
9. Fosfomycin, antimicrobial activity in vitro and in vivo.
Goto S
Chemotherapy; 1977; 23 Suppl 1():63-74. PubMed ID: 401721
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey.
Demir T; Buyukguclu T
Int J Infect Dis; 2013 Nov; 17(11):e966-70. PubMed ID: 23742831
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
Inouye S; Hara T; Matsuhashi Y; Kitasato I
Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
Yoshida T; Tateda E; Hiramatsu K; Yokota T
Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
[TBL] [Abstract][Full Text] [Related]
13. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study.
Bielen L; Likić R; Erdeljić V; Mareković I; Firis N; Grgić-Medić M; Godan A; Tomić I; Hunjak B; Markotić A; Bejuk D; Tičić V; Balzar S; Bedenić B
Croat Med J; 2018 Apr; 59(2):56-64. PubMed ID: 29740989
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
15. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
Candel FJ; Matesanz David M; Barberán J
Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activities of K-4619, a new semisynthetic aminoglycoside.
Saino Y; Hattori Y; Koshi T; Kobayashi F; Oda T; Mitsuhashi S
Antimicrob Agents Chemother; 1984 Aug; 26(2):187-91. PubMed ID: 6548350
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial kinetics of fosfomycin (author's transl)].
Gevaudan MJ; Mallet MN; Charrel J; Dalmas N; Gulian C; Gevaudan P
Ann Biol Clin (Paris); 1979; 37(6):327-30. PubMed ID: 547759
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of fosfomycin in vitro.
Forsgren A; Walder M
J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
[TBL] [Abstract][Full Text] [Related]
19. Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal
Ito R; Mustapha MM; Tomich AD; Callaghan JD; McElheny CL; Mettus RT; Shanks RMQ; Sluis-Cremer N; Doi Y
mBio; 2017 Aug; 8(4):. PubMed ID: 28851843
[TBL] [Abstract][Full Text] [Related]
20. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
Lindenschmidt EG; Schassan HH
Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
